Results 201 to 210 of about 32,386 (229)

HUMIRA (adalimumab)

SKINmed: Dermatology for the Clinician, 2004
William, Abramovits, Aditya K, Gupta
openaire   +2 more sources

Adalimumab

Reactions Weekly, 2008
  +4 more sources

Adalimumab

Reactions Weekly, 2017
  +4 more sources

Adalimumab

Reactions Weekly, 2015
openaire   +2 more sources

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

Gut, 2011
Walter Reinisch, Geert D'Haens, Remo Panaccione   +2 more
exaly  

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

Lancet, The, 2016
Quan Dong Nguyen, Pauline T Merrill, Andrew D Dick   +2 more
exaly  

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Lancet, The, 2017
Roy M Fleischmann, Robert J Moots, Liza Takiya   +2 more
exaly  

Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial

Gut, 2007
Richard Fedorak, Milan Lukas, Remo Panaccione   +2 more
exaly  

The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

Arthritis and Rheumatism, 2006
Stanley B Cohen, Karel Pavelka
exaly  

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Gut, 2018
Maria Nachury, Matthieu Allez, Laurent Peyrin-Biroulet   +2 more
exaly